News

---

Hyperhidrosis: A common condition GPs can now actively manage

---

Excessive sweating is easily dismissed as a cosmetic concern, but for patients living with hyperhidrosis, it is a chronic medical condition with real consequences for daily life.
 
Research consistently shows that the quality‑of‑life burden associated with hyperhidrosis is comparable to that experienced by patients with psoriasis, eczema or acne.
 
Hyperhidrosis is characterised by excessive sweating that exceeds what is required for thermoregulation.
 
Primary hyperhidrosis most often presents in a focal pattern, commonly the axillae, palms, soles or face, and typically begins in adolescence or early adulthood, with no underlying systemic cause.
 
Despite affecting an estimated 1.2 million Australians, hyperhidrosis remains under‑diagnosed.
 
Many patients delay seeking help due to embarrassment or a belief that nothing more than over‑the‑counter antiperspirants is available. Surveys suggest that only a minority of patients with troubling symptoms ever raise the issue with their GP.
 
The impact of hyperhidrosis extends well beyond physical discomfort.
 
Studies using validated instruments, such as the Dermatology Life Quality Index, demonstrate significant impairment across social, emotional and occupational domains, with burden that can exceed that of more widely recognised dermatological conditions, including psoriasis, eczema and acne. Patients frequently describe:

• avoidance of social and professional situations
• difficulty with work tasks and manual activities
• reduced confidence and increased anxiety
• negative effects on clothing choices and daily routines.

This burden is often out of proportion to the visible clinical signs, making active enquiry by GPs particularly important.
 
The diagnosis of primary focal hyperhidrosis is clinical and can usually be made in general practice. Key features include:
 

• focal, bilateral sweating (e.g. axillae)
• onset before the age of 25 years
• absence of sweating during sleep
• positive family history in some cases.

Secondary causes should be considered where presentation is atypical, generalised, or associated with systemic symptoms or medication use.
 
Traditional first‑line management has relied heavily on aluminium‑based antiperspirants, which reduce sweating by forming temporary plugs in the sweat glands. While appropriate, these treatments are often poorly tolerated or insufficient for patients with moderate‑to‑severe disease.
 
In the past, limited intermediate options meant that patients were either left undertreated or referred early for injectables or procedural therapies.
 
Management pathways have now evolved. Evidence‑based guidelines increasingly recognise hyperhidrosis as a legitimate chronic condition requiring stepwise escalation, similar to other dermatological disorders.
 
Crucially for Australian general practice, there is now PBS‑listed medication available for primary hyperhidrosis that interrupts the sweat signalling pathway, expanding the role of GPs in active management. This has prompted a call for GPs to:
 

• treat excessive sweating conditions in primary care
• provide PBS prescription medicine as an option for patients
• reduce delays in access to treatment and unnecessary referral.

Because patients may normalise or minimise their symptoms, proactive questioning can be valuable.
 
Simple prompts such as ‘Do you ever worry about sweating more than others?’ or ‘Do you have to change your clothes more than once daily due to sweating?’ can uncover difficulties that patients have lived with for years.
 
Framing hyperhidrosis as a recognised medical condition, and not a cosmetic complaint, can be highly validating for your patients.
 
Hyperhidrosis is common, impactful and increasingly manageable in primary care.
 
With PBS-listed prescription treatment now available, GPs are well placed to identify and treat patients who previously felt they had no options beyond the pharmacy shelf. Furthermore, referral to specialist dermatologists is still an option where escalation is required.
 
Recognising hyperhidrosis as a condition worth addressing may significantly improve patient quality of life and reinforce the value of GP‑led care for this often-overlooked disorder.
 
Log in below to join the conversation.

---

hyperhidrosis

---